登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Nature，4月6日，Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-04-07

  • Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy

    Jeffrey D. Jensen & Michael Lynch

    Heredity (2020)

    With the rapid global spread of SARS-CoV-2, tremendous efforts have been focused upon potential treatment strategies (Li and De Clercq 2020). Evolutionary theory has an important role to play in this search, and we here discuss one potentially under-appreciated research avenue.

  • 原文来源：https://www.nature.com/articles/s41437-020-0314-z
35浏览量
原文链接
相关报告

  • 《Nature，5月4日，A human monoclonal antibody blocking SARS-CoV-2 infection》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-05-05
    • A human monoclonal antibody blocking SARS-CoV-2 infection Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, Frank J. M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld & Berend-Jan Bosch Nature Communications volume 11, Article number: 2251 (2020) Abstract The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.
    319浏览量
    原文链接

  • 《Nature，5月6日，Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-05-07
    • Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2 Kazuma Kiyotani, Yujiro Toyoshima, Kensaku Nemoto & Yusuke Nakamura Journal of Human Genetics (2020) Abstract To control and prevent the current COVID-19 pandemic, the development of novel vaccines is an emergent issue. In addition, we need to develop tools that can measure/monitor T-cell and B-cell responses to know how our immune system is responding to this deleterious virus. However, little information is currently available about the immune target epitopes of novel coronavirus (SARS-CoV-2) to induce host immune responses. Through a comprehensive bioinformatic screening of potential epitopes derived from the SARS-CoV-2 sequences for HLAs commonly present in the Japanese population, we identified 2013 and 1399 possible peptide epitopes that are likely to have the high affinity (<0.5%- and 2%-rank, respectively) to HLA class I and II molecules, respectively, that may induce CD8+ and CD4+ T-cell responses.
    101浏览量
    原文链接